Scope of the Study
NGS Sample Preparation is defined as technology in which millions, as well as billions of DNA strands, can be sequenced through massive parallelization. It is also identified as a high throughput sequencing. Growth in the number of genome mapping programs throughout the world and increase in R&D investment, among others will, in turn, propel the growth of hemp milk market. The market for NGS Sample Preparation is expected to register a CAGR of over 21.2% during the forecast period
The market study is being classified by Type (Reagent and Workstations), by Application (Infectious Disease and Cancer Diagnostics) and major geographies with country level break-up.
Illumina Inc. (United States), Thermo Fisher Scientific (United States), QIAGEN N.V. (Germany), Agilent Technologies, Inc. (United States), Beckman Coulter (a subsidiary of Danaher),, Becton, Dickinson, and Company (United States), Pacific Biosciences of California (United States), F. Hoffmann-La Roche AG (Switzerland), New England Biolabs, Inc. (United States) and Nugen Technologies, Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Oxford Gene Technology IP Limited (United Kingdom), Oxford Nanopore Technologies, Ltd. (United Kingdom), Perkinelmer, Inc. (United States) and Swift Biosciences Inc. (United States.
The market is fragmented with numerous players focusing on technique and quality of the product due to which the global NGS sample preparation market can witness an upsurge in the forecast period. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global NGS Sample Preparation market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global NGS Sample Preparation market by Type, Application and Region.
On the basis of geography, the market of NGS Sample Preparation has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Technology , the sub-segment i.e. SMRT will boost the NGS Sample Preparation market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Workflow, the sub-segment i.e. Library Preparation will boost the NGS Sample Preparation market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Advancements in NGS Platforms
- Declining Cost of Sequencing
- Improving Reimbursement Scenario for NGS-Based Diagnostic Tests
- Technology Advancement in NGS Sample Preparation
- End User Budget Constraints in Developing Countries
- High-Cost Factor associated with reagent and Sample Preparation for Testing
- Initiatives as well as Funding from Government & Private Bodies for Large-Scale Sequencing Projects
- Increasing Applications of Next Generation Sequencing (NGS)
- Ethical Issues Regarding the Sample Taken From For Testing
Market Leaders and their expansionary development strategies
In November 2018, the Illumina Inc. (United States) has entered into an agreement to acquire Pacific Biosciences of California, Inc. (United States) Company for more than USD 1.2 Billion. Henceforth, this would help in enhancing the customer base of the company. and In August 2018, the Tecan Group Ltd. (Switzerland ) Company has acquired NuGEN Technologies, Inc. (United States) Company, which is a United States based sequencing sample prep company. Therefore, it will affect therewith of, the market in the future.
In January 2019, the QIAGEN N.V. (Germany) Company launched its QIAcube Connect, which automates the lysis, bind, wash, and elute steps of the Qiagen spin columns. Hence, this will, in turn, propel the growth of NGS Sample Preparation market. and In April 2018, the Thermo Fisher Scientific (United States) Company has launched its Oncomine Childhood Cancer Research Assay, which is a comprehensive, next-generation sequencing (NGS) panel. Consequently, this launch will help in strengthening the position of the company
Key Target AudienceManufacturers of Next Generation Sequencing, Research and Development (R&D) Companies, Research Organization, Federal Agencies and Others
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase